Cargando…

CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients

Cisplatin-based chemotherapy is the foundation of treatment for major non-small cell lung cancer (NSCLC) patients. However, cisplatin resistance is still a challenging issue, and the molecular mechanisms underlying this resistance remain to be fully explored. CLEC4M, a Ca(2+)-dependent C-type lectin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Li-Ming, Li, Xi, Qiu, Cheng-Feng, Zhu, Tao, Hu, Cheng-Ping, Yin, Ji-Ye, Zhang, Wei, Zhou, Hong-Hao, Liu, Zhao-Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856750/ https://www.ncbi.nlm.nih.gov/pubmed/31772670 http://dx.doi.org/10.7150/jca.30139

Ejemplares similares

Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma
por: Zhang, Yanqiu, et al.
Publicado: (2023)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)

PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
por: Li, Ming, et al.
Publicado: (2017)

Overexpression of CLEC18B Associates With the Proliferation, Migration, and Prognosis of Glioblastoma
por: Guo, Rui-Ming, et al.
Publicado: (2018)

CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma
por: Yu, Qianle, et al.
Publicado: (2020)

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
por: Yin, Chengliang, et al.
Publicado: (2021)

Decreased Preoperative Estimated Glomerular Filtration Rate Was Related With Poor Prognosis of NSCLC Patients
por: Jia, Wenqiao, et al.
Publicado: (2020)

SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling
por: Chen, Tai-yu, et al.
Publicado: (2022)

Investigation of Diagnostic and Prognostic Value of CLEC4M of Non-Small Cell Lung Carcinoma Associated with Immune Microenvironment
por: Liu, Huan, et al.
Publicado: (2023)

Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
por: Ma, Yu-Shui, et al.
Publicado: (2021)

SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
por: Lv, Hong-Wei, et al.
Publicado: (2021)

Polymorphisms of CLEC16A Region and Autoimmune Thyroid Diseases
por: Muhali, Fatuma-Said, et al.
Publicado: (2014)

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2016)

CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
por: Sung, Pei-Shan, et al.
Publicado: (2019)

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
por: Chen, Rui, et al.
Publicado: (2022)

Inhaled Cisplatin for NSCLC: Facts and Results
por: Kosmidis, Christoforos, et al.
Publicado: (2019)

Inhibition of DNA-PK by gefitinib causes synergism between gefitinib and cisplatin in NSCLC
por: Pan, Chi, et al.
Publicado: (2020)

Inhibition of SARS‐CoV‐2‐mediated thromboinflammation by CLEC2.Fc
por: Sung, Pei‐Shan, et al.
Publicado: (2023)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

The Origin and Evolution of Variable Number Tandem Repeat of CLEC4M Gene in the Global Human Population
por: Li, Hui, et al.
Publicado: (2012)

MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
por: Fang, Chao, et al.
Publicado: (2017)

Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017)

CLEC5A mediates Zika virus-induced testicular damage
por: Wang, Hsin-Wei, et al.
Publicado: (2023)

YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC
por: Cui, Yanwei, et al.
Publicado: (2020)

Non-Cirrhotic Liver is Associated with Poor Prognosis of Hepatocellular Carcinoma: A Literature Review
por: Liu, Yan, et al.
Publicado: (2019)

Platelet CLEC‐2 and lung development
por: Suzuki‐Inoue, Katsue, et al.
Publicado: (2020)

Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
por: Fang, Chao, et al.
Publicado: (2021)

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
por: Hao, Yanzhang, et al.
Publicado: (2014)

Correction: Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022)

Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection
por: Chan, Vera S F, et al.
Publicado: (2005)

Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection
por: Zhi, Lianteng, et al.
Publicado: (2007)

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
por: Huang, Gang, et al.
Publicado: (2017)

Genetic association analysis of CLEC5A and CLEC7A gene single-nucleotide polymorphisms and Crohn’s disease
por: Elleisy, Nagi, et al.
Publicado: (2020)

Long noncoding RNA AFAP1-AS1 is upregulated in NSCLC and associated with lymph node metastasis and poor prognosis
por: Leng, Xuechun, et al.
Publicado: (2018)

Clec7a drives gut fungus-mediated host lipid deposition
por: Ma, Jie, et al.
Publicado: (2023)

CLEC5A is critical in Pseudomonas aeruginosa–induced NET formation and acute lung injury
por: Sung, Pei-Shan, et al.
Publicado: (2022)

High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer
por: Wu, Qi, et al.
Publicado: (2019)

EGFR Mutation-Harboring Lung Cancer Cells Produce CLEC11A with Endothelial Trophic and Tumor-Promoting Activities
por: Lin, Tzu-Yin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ana6jfoq22ovt0lnn0uvt44rpp